Seres Therapeutics, Inc. (MCRB) Executive Compensation
Seres Therapeutics, Inc. (MCRB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MCRB
CIK: 1609809
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHolly Reeves
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-08-21 | — | EFFECT Filing | 9999999995-26-002733 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355734 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355722 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355718 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 | 0001193125-26-355712 | View SEC Doc Filr Page |
| S-3 | 2026-08-13 | — | S-3 | 0001193125-26-349330 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-334174 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-333820 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-31 | 8-K | 0001193125-26-332742 | View SEC Doc Filr Page |
| 424B5 | 2026-08-04 | — | 424B5 | 0001193125-26-332730 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300927 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300925 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300923 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300922 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300921 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300920 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300918 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300916 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300926 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300924 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300919 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300914 | View SEC Doc Filr Page |
| S-8 | 2026-07-09 | — | S-8 | 0001193125-26-299675 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-08 | 8-K | 0001193125-26-298525 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-08 | 8-K | 0001193125-26-298005 | View SEC Doc Filr Page |